A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease
Bone Marrow Transplant
.
2020 Dec;55(12):2343-2346.
doi: 10.1038/s41409-020-0953-y.
Epub 2020 May 28.
Authors
Richard K Burt
1
,
Robert Craig
2
,
Laura Yun
2
,
Amy Halverson
3
,
Kathleen Quigley
4
,
Indira Arnautovic
4
,
Xiaoqiang Han
4
Affiliations
1
Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. rburt@northwestern.edu.
2
Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
3
Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
4
Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
PMID:
32467584
DOI:
10.1038/s41409-020-0953-y
No abstract available
Publication types
Letter
MeSH terms
Crohn Disease* / therapy
Feasibility Studies
Hematopoietic Stem Cell Transplantation*
Humans
Myeloablative Agonists
Transplantation Conditioning
Substances
Myeloablative Agonists